Gérard Zurawski

Inserm — France

Immunology and Microbiology · Life Sciences

61h-index20.8kcitations183works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(79), Immune Cell Function and Interaction(55), T-cell and B-cell Immunology(52), HIV Research and Treatment(20), vaccines and immunoinformatics approaches(20)

Publications183 total

Targeting Langerhans cells via skin delivery of HIV Envelope enhances the antibody response to vaccination
npj Vaccines·2025Open Access
Langerhans cells drive Tfh and B cell responses independent of canonical cytokine signals
Frontiers in Immunology·2025Open Access
Langerhans Cells Drive Tfh and B Cell Responses Independent of Canonical Cytokine Signals
2025· 1 citedOpen Access
Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells
EBioMedicine·2024· 5 citedOpen Access
157P Preliminary results of a multicentric randomized phase I/IIa trial of an immunotherapy targeting dendritic cells (DC), CD40HVac, in patients with HPV16-positive oropharyngeal carcinoma (OPC)
Immuno-Oncology Technology·2024· 1 citedOpen Access
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06)
EClinicalMedicine·2024· 10 citedOpen Access
Cancer Cells Promote Immune Regulatory Function of Macrophages by Upregulating Scavenger Receptor MARCO Expression
The Journal of Immunology·2023· 18 cited
Steady-state Langerhans cells induce Tfh and B cell responses through a type I interferon and IL-6 independent mechanism
The Journal of Immunology·2023· 1 citedOpen Access
Data from Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8<sup>+</sup> T-cell Immunity
2023Open Access
Data from Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8<sup>+</sup> T-cell Immunity
2023Open Access
Supplementary Materials and Methods and Supplementary Figures 1-5 from Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8<sup>+</sup> T-cell Immunity
2023Open Access
Supplementary Materials and Methods and Supplementary Figures 1-5 from Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8<sup>+</sup> T-cell Immunity
2023Open Access
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
eLife·2022· 19 citedOpen Access
Antibody-mediated targeting of a hybrid-insulin-peptide towards neonatal thymic Langerin+ cells enhances T cell central tolerance and delays autoimmune diabetes
2022Open Access
Antibody-mediated targeting of a hybrid-insulin-peptide towards neonatal thymic Langerin+ cells enhances T cell central tolerance and delays autoimmune diabetes
2022Open Access
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
EBioMedicine·2022· 25 citedOpen Access
Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines
Frontiers in Immunology·2022· 23 citedOpen Access
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
2021Open Access
A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires
Frontiers in Immunology·2021· 4 citedOpen Access
SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines
2021Open Access
page 1 of 10Next →

Frequent Co-authors

Jacques Banchereau(9), Sandra Zurawski(9), Sandra Zurawski(6), J E de Vries(5), Eynav Klechevsky(5), Michael T. Clegg(5), Wilhelm Gruissem(5), Charles Yanofsky(5), Daniel M. Gorman(4), Hideki Ueno(4), Satish Menon(4), W. Bottomley(4), Paul R. Whitfeld(4), Nathalie Schmitt(3), Virginia Pascual(3), René de Waal Malefyt(3), Yanying Cao(3), LuAnn Thompson-Snipes(3), Karolina Palucka(3), Anne-Laure Flamar(3)